查看分析师 EPS 与营收区间、覆盖人数，以及过去 7、30、90 天的预期变化。缺失修正不会显示成零；分析师人数较少的公司默认不进入排名。
默认至少 3 位分析师。没有历史值、EPS 非正值或历史 EPS 过于接近零时显示“—”，不会用失真的百分比参与排名。
榜单优先使用当前财年 EPS；营收修正由每日快照逐步积累，首日不会生成伪历史。
| +9.84% |
| +27.54% |
| 6 / 0 |
| $40.15B |
| TSM Taiwan Semiconductor Manufacturing Company Ltd. | 16.82 2026-12-31 | 15.23 – 17.57 | 13 | +0.71% | +6.26% | +8.82% | 3 / 0 | $5.41T |
| NUTX Nutex Health Inc. Common Stock | 21.52 2026-12-31 | 15.2 – 24.37 | 5 | +1.41% | +2.38% | +15.30% | 2 / 0 | $880.37M |
| PEN Penumbra Inc. Common Stock | 4.98 2026-12-31 | 4.35 – 5.43 | 13 | +0.42% | +2.14% | -0.99% | 0 / 1 | $1.59B |
| GPC Genuine Parts Company Common Stock | 7.74 2026-12-31 | 7.6 – 7.85 | 10 | +0.55% | +0.47% | +0.68% | 3 / 4 | $25.54B |
| SSD Simpson Manufacturing Company Inc. Common Stock | 9.06 2026-12-31 | 9 – 9.2 | 4 | +0.38% | +0.38% | +0.38% | 1 / 0 | $2.42B |
| NTNX Nutanix Inc. Class A Common Stock | 1.93 2026-07-31 | 1.86 – 1.96 | 17 | +0.22% | +0.22% | +5.47% | 16 / 0 | $2.83B |
| NCDL Nuveen Churchill Direct Lending Corp. Common Stock | 1.57 2026-12-31 | 1.53 – 1.64 | 5 | +0.20% | +0.20% | -5.15% | 0 / 5 | $185.18M |
| SUPN Supernus Pharmaceuticals Inc. Common Stock | 2.49 2026-12-31 | 2.11 – 2.95 | 3 | 0.00% | 0.00% | +6.27% | 0 / 0 | $867.18M |
| MFC Manulife Financial Corporation Common Stock | 4.46 2026-12-31 | 4.33 – 4.61 | 14 | +0.03% | -0.23% | -1.17% | 1 / 10 | $49.83B |
| UNM Unum Group Common Stock | 8.74 2026-12-31 | 8.65 – 8.87 | 13 | -0.56% | -0.47% | -0.00% | 2 / 0 | $12.67B |
| NU Nu Holdings Ltd. Class A Ordinary Shares | 0.81 2026-12-31 | 0.63 – 0.89 | 14 | +0.06% | -1.04% | -3.04% | 2 / 6 | $22.32B |
| MOD Modine Manufacturing Company Common Stock | 7.66 2027-03-31 | 6.99 – 8.26 | 7 | -1.82% | -1.95% | +3.80% | 7 / 1 | $4.06B |
| NTR Nutrien Ltd. Common Shares | 5.57 2026-12-31 | 4.98 – 6.77 | 21 | -2.09% | -4.63% | -0.49% | 2 / 2 | $27.95B |
| INUV Inuvo Inc. | 0.15 2026-12-31 | -0.36 – 0.93 | 3 | — | -63.33% | — | 2 / 0 | $33M |
| DNUT Krispy Kreme Inc. Common Stock | -0.01 2026-12-31 | -0.11 – 0.05 | 5 | — | — | — | 1 / 0 | $1.36B |
| JANX Janux Therapeutics Inc. Common Stock | -1.76 2026-12-31 | -2.54 – -0.81 | 14 | — | — | — | 0 / 0 | $31.59M |
| JBI Janus International Group Inc. Common Stock | 0.58 2026-12-31 | 0.5 – 0.62 | 4 | 0.00% | — | -9.45% | 0 / 4 | $956.52M |
| NNE Nano Nuclear Energy Inc. Common Stock | -0.9 2026-09-30 | -1.14 – -0.75 | 6 | — | — | — | 3 / 1 | $1.02M |
| NRIX Nurix Therapeutics Inc. Common stock | 1.79 2026-11-30 | -2.98 – 3.82 | 4 | — | — | — | 3 / 1 | $755.34M |
| NVCT Nuvectis Pharma Inc. Common Stock | -1.01 2026-12-31 | -1.16 – -0.88 | 5 | — | — | — | 1 / 0 | $0 |
| QNT Quantinuum Inc. Class A Common Stock | -1.4 2026-12-31 | -1.63 – -1.07 | 11 | — | — | — | 0 / 0 | $26.47M |
| SMR NuScale Power Corporation Class A Common Stock | -0.51 2026-12-31 | -0.66 – -0.35 | 9 | — | — | — | 3 / 2 | $53.48M |